iifl-logo

Tonira Pharma Ltd merged Company Summary

Add as a Preferred Source on Google
19.75
(2.07%)
May 29, 2012|05:30:00 AM

Tonira Pharma Ltd merged Summary

Incorporated as a private limited company in Aug.92 to take over the running business of Pharmachem Laboratories, Tonira Pharma is engaged in the manufacture of bulk drugs at its plant located in Ankleshwar, Gujarat. The company presently manufacture cardio vascular and anti-ulcer drugs and drugs intermediates like atenolol, nifidipine PHAP, OHAP, PHPA, sulphamide, PHPAA acetamide and 1-3 dichloro acetone.The company came out with a public issue in Feb.95 to part-finance its expansion-cum-diversification programme of increasing its intsalled capacity and also setting up a new formulation unit. Its clients include Dabur India, Cadila Laboratories, Sol Pharmaceuticals, IPCA Laboratories, Nicholas Laboratories, Zandu Pharmaceuticals, Neuland Laboratories, Anglo-French, Catazyme Drugs & Pharmaceuticals, Glaxo India, etc.Exports are presently made to 16 countries, mainly in Europe, South America, Singapore and Egypt.

It has strategic alliance with many overseas companies which include Schweizerhall (Singapore/Germany); Deshores, France; Nutrivete Corporation, US; Chemo Iberica, Switzerland; Samaha Company, Egypt and Pharmaline, Italy.By launching value added products and by inculcating Total Quality Management across the organisation the company is expecting Good Export business in the near future.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.